Low-dose ketamine is an efficacious antidepressant for treatment-resistant unipolar and bipolar depressed patients. Major Depression Disorder patients receiving a single infusion report elevated mood within two hours, and ketamine's antidepressant effects have been observed as long as seven days post-treatment. In light of this remarkable observation, efforts have been undertaken to "reverse-translate" ketamine's effects to understand its mechanism of action. Major advances have been achieved in understanding the molecular, cellular, and circuit level changes that are initiated by lowdose ketamine. Although enhancement of protein synthesis clearly plays a role, the field lacks a comprehensive understanding of the protein synthesis program initiated after ketamine treatment. Here, using ribosome-bound mRNA footprinting and deep sequencing (RiboSeq), we uncover a genome-wide set of actively translated mRNAs (the translatome) in medial prefrontal cortex after an acute antidepressant-like dose of ketamine. Gene Ontology analysis confirmed that initiation of protein synthesis is a defining feature of antidepressant-dose ketamine in mice and Gene Set Enrichment Analysis points to a role for GPCR signaling, metabolism, vascularization, and structural plasticity in ketamine's effects. One gene, VIPR2, whose protein product VPAC2 acts as a GPCR for the neuropeptide vasoactive intestinal peptide, was characterized in cortex and identified as a potential novel target for antidepressant action.
Introduction
Depression is the leading psychiatric cause of disability globally 1 , and first-line therapies targeting the monoamine system are ineffective in a significant population of depressed patients [2] [3] [4] . In patients that do respond to first-line therapies, weeks to months of continuous treatment are necessary to reach peak therapeutic efficacy. A single infusion of the n-methyl d-aspartate (NMDA) glutamate receptor antagonist ketamine elicits an antidepressant response within 110 minutes of administration 5 . While ketamine has a serum half-life on the order of hours, the antidepressant effects of a single low dose can persist for as long as a week in treatment-resistant MDD patients 5 . What then is the basis for this long-lasting effect? Several groups have reported that ketamine and specific antagonists of GluN2B-containing NMDA receptors rapidly induce protein synthesis: in these studies, differential regulation of a handpicked subset of candidate proteins was observed [6] [7] [8] . between mRNA expression and protein synthesis, and can be dynamically directed by intrinsic and extrinsic cues to suppress, or permit, translation of a given transcript [11] [12] [13] . Additionally, NMDAR modulation is known to both promote and repress gene transcription and activate complex transcriptional networks where clear predictions on protein expression changes are difficult. 14 For these reasons, we sought to assess the complement of mRNAs that are actively translated in response to ketamine, in order to identify the cellular signaling pathways underlying this long-lasting antidepressant effect. Ribosome-bound mRNA profiling involves isolation and deep sequencing of mRNAs being translated at the ribosome at a given point in time 15 , and provides a quantitative and genome-wide assessment of genes differentially regulated in a given condition. Here, we used ribosomae-bound mRNA profiling (RiboSeq) to compare translational regulation in the medial prefrontal cortex (mPFC) of mice injected with either saline, an antidepressant (low) dose of ketamine, or a non-antidepressant (high) dose of ketamine. Gene-set analysis demonstrated that low, but not high dose ketamine strongly upregulated pathways involved in the initiation and regulation of protein synthesis, and revealed significant enrichment of 17 diverse gene sets, and down regulation of 7. We selected VPAC2, a receptor for endogenous vasoactive intestinal peptide (VIP), for further analysis based on large fold-change, high significance, and pharmacological tractability. We demonstrate that VPAC2 is functionally expressed specifically in somatostatin-positive (SOM+) inhibitory interneurons, and that activation of VPAC2 enhances excitability of SOM+ interneurons in mPFC. VPAC2 might serve as a target for future antidepressant interventions and as a target for modulating the SOM+ inhibitory neuron network in mPFC.
Results

Calibration of ketamine's antidepressant effects
Although ketamine's long-lasting antidepressant-like effects in rodents are robust and replicable, the exact dosage necessary to elicit such an effect varies depending on species, strain, age, sex, and even animal housing and handling conditions [16] [17] [18] [19] [20] . Therefore, we first sought to calibrate our in-house antidepressant dose before undertaking genomic analysis ( Figure 1A ). Compared to saline- 
Isolation of actively translating mRNAs and quality control
Animals from all groups were handled for 5 minutes per day for 7 days before treatment in order to habituate the mice and reduce experimentally-irrelevant translation changes due to handling.
Thirty minutes after saline or ketamine treatment, mice were rapidly sacrificed and tissue from mPFC was isolated. Samples were processed to obtain both total mRNAs (for RNA-Seq) and ribosomebound mRNA fragments (for RiboSeq). Quality control of the data confirmed the prefrontal-cortical identity of the mRNA samples 21 (Supplemental Figure 1) . Bioinformatic analysis revealed a set of differentially expressed genes (DEGs) and differentially translated genes (DTGs) in response to low-and high-dose ketamine treatment.
Profiling the translatome after antidepressant ketamine
One proposed mechanism by which low-dose ketamine might exert its antidepressant effects is by blocking NMDARs on inhibitory interneurons in mPFC and causing cortical disinhibition [22] [23] [24] Figure 2) . This is consistent with other mechanisms of induction including engagement of homeostatic plasticity 24, 25 .
Dysregulation of biological pathways and functional gene sets contribute to manifestation of depression-related behaviors 26 . Gene In contrast to GO, classification by Gene Set Enrichment Analysis (GSEA) is designed to detect changes in groups of functionallyrelated genes whose expression is coordinately regulated 30, 31 . GSEA analysis revealed that low-dose ketamine alters the expression of diverse gene sets involved in GPCR signaling, neuronal metabolism, vascularization, and structural plasticity ( Figure 3B ). Of particular interest is the robust 1.83-fold increase in enrichment of the GPCR gene set. This gene set's enrichment is driven by core enrichment of G-protein GNG4, serotonin receptor HTR1D, and VIP receptor VIPR2, among others ( Figure 3C ).
Interestingly, the GSEA gene sets that were downregulated after low-dose ketamine are primarily involved in the replication of mitotic cells ( Figure 3D ). Together, these data suggest that an antidepressant dose of ketamine increases GPCR signaling, metabolism, and structural reorganization, while potentially limiting the genesis of new glia or other mitotic cell types. Figure 2 . Ribosome-bound mRNA profiling workflow. After seven days of handling, mice were injected with saline, low dose (3mg/kg), or high dose (100mg/kg) ketamine and sacrificed 30 minutes later. mPFC tissue was collected and rapidly frozen. Tissue was processed to obtain total mRNA (for RNA-seq) and ribosome protected mRNA (for ribosome-bound mRNA profiling), and cDNA libraries were produced and sequenced. cDNA reads were mapped to the mouse genome to assess differentially expressed genes and for gene set pathway analysis. Finally, we manually selected candidate genes based on high fold-change, tractability, presumed safety, and novelty. The GPCR gene set and the GPCR VPAC2 were of particular interest to us based on high fold change, pharmacological accessibility, and the fact that its role in depression is unstudied. We identified that action potential firing in SOM+ inhibitory interneurons is uniquely enhanced by VPAC2 agonism in mPFC.
The functional specificity of VPAC2 to SOM+ interneurons is an interesting finding in light of recently produced cell-type specific RNA-seq data, which demonstrates Vipr2 mRNA present in not only SOM+, but also in PV+ and Reelin/HTR3A+ interneurons 55 . As VPAC2 is primarily a Gs-coupled GPCR, it is possible that in PV interneurons Gs signaling does not link to pathways that regulate cell excitability. Alternatively, it is possible that cAMP activation does not couple to intracellular pathways that directly alter firing probability in PV interneurons.
Although a role for VPAC2 in major depression has not, to our Juveniles were group-housed to not more than three mice per cage.
Male mice 2-3 months of age were used at the time of analysis for all physiology, behavior, and histology studies
Mice
GluN2B-Floxed Mice
Mice with exon 5 of the GRIN2B gene flanked by loxP sites were used for all experiments to maintain the same background as experiments from previous studies 8, 57 . At no point in this study were GluN2B-floxed mice exposed to Cre, and therefore these mice are wild-type at the protein level.
Ai14 Mice
The 
Bioinformatic analysis:
Data processing and bioinformatics analysis was performed as previously described 59 . In short, linker tags were removed from RNA sequencing and ribosome-bound mRNA profiling reads by the FASTX Toolkit, all reads that mapped to rRNAs, tRNAs or mitochondrial rRNAs were removed, and the remaining reads were mapped to RefSeq (v38) by TopHat. Finally all read counts that mapped uniquely to genes were extracted for expression analysis.
We applied the edgeR algorithm 60 for differential gene expression analysis and identified genes with change larger than 150% or less than 70% of saline control levels, and Benjamini-Hochberg adjusted p value less than 0.01 as significantly changed. We applied the camera algorithm 61 for gene set enrichment analysis with gene sets collected in the Roche internal database RONET. Gene ontology enrichment analysis was performed using the Fisher's exact test.
Electrophysiology Slice preparation
As previously descibed 8, 62 , for acute slice recordings, adult 2-3 months old mice were anesthetized with isoflurane and decapitated. The brain was rapidly removed and placed into icecold modified NMDG solution (composition in mM: 110 NMDG, 110
HCl, 3 KCl, 10 MgCl2 6*H20, 1.1 NaH2PO4 H20, 0. At baseline for SOM and PYR neurons, action potentials were evoked by small current injections, sufficient to elicit 4-6 action potentials. For PV neurons, a baseline of 4-6 APs was unattainable, so the minimum stimulus necessary to evoke burst firing was used.
After a minimum of 5 minutes of baseline recording, Bay55
([maximal] 367.1±19.33nM, as assayed by mass spectrometry) was perfused into the bath for 5 minutes, and the recordings continued unadjusted for the entirety of recording (up to one hour). Graphs are displayed as running averages of three sequential sweeps.
Mouse Behavior Open Field Test
Open field test was conducted using Accuscan open field system.
Mice were introduced into the arena at a fixed corner of an acrylic (42 x 42 x 30.5 cm) field arena and allowed to explore the arena freely. The arena was cleaned in between subjects with 70% ethanol.
Forced Swim Test
Forced swim test was carried out as previously described 63, 64 .
Briefly, mice were introduced to a cylinder filled with room temperature water. The cylinder was 15 cm in diameter by 20cm
height and filled to 15 cm (sufficient to prevent mice from using tails to support themselves) with room temperature water (23-26˚C). Two to four mice were tested simultaneously with a screen to separate the cylinders. Videos were recorded from a topmounted camera for 6 min. After the testing, mice were rubbed dry and placed under an infrared lamp for about 20 min. Immobility in the last 4 min of 6 min test session was scored blind to genotype and treatment. The cylinders were cleaned in between subjects with 70% ethanol. Supplemental Figure 2 . RNA-seq assessment of immediate early genes Supplemental Figure 2 . RNA-seq assessment of immediate early genes Analysis of immediate early gene mRNA expression demonstrates that high-dose, but not-low dose ketamine initiates activity-dependent expression of mRNAs, relative to saline control (dotted vertical bar). (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001) Supplemental Figure 4 . Activation of SOM+ interneurons by VPAC2 agonism is G-protein-dependent After establishing a baseline of excitability in response to a stable current injection, perfusion of VPAC2-specific agonist Bay55 did not alter action potential firing in Somatostatin+ interneurons in mPFC when GDPβS was included in the patch pipette.
